Glucosio Con Sodio Cloruro Iii Monico (Sodium Chloride, Glucose Monohydrate)

Glucosio Con Sodio Cloruro Iii Monico is indicated for several clinical situations where fluid, electrolyte, and carbohydrate support are required. It is commonly employed in hospital and emergency environments.

• Replacement of fluid losses due to dehydration, surgery, or trauma
• Correction of electrolyte disturbances, especially sodium and chloride deficits
• Treatment of mild to moderate hypoglycemia when oral intake is not feasible
• Support of parenteral nutrition regimens as a carbohydrate source
• Maintenance of intravascular volume during anesthesia or critical care

Side effects of sodium chloride and glucose monohydrate injection are generally infrequent but may occur with any intravenous therapy. Monitoring during administration helps identify and manage reactions.

Common

• Mild local irritation or pain at the injection site
• Transient increase in blood glucose levels
• Slight elevation of serum sodium concentration
• Temporary feeling of warmth or flushing

Serious

• Severe hypernatremia leading to neurological symptoms
• Significant hyperglycemia requiring medical intervention
• Allergic reaction such as urticaria, rash, or anaphylaxis
• Fluid overload causing pulmonary edema or heart failure
• Electrolyte imbalance with marked shifts in chloride levels

When using Glucosio Con Sodio Cloruro Iii Monico, clinicians should observe several safety considerations to minimize risk. Proper patient assessment and monitoring are essential.

• Verify patient’s electrolyte status and glucose levels before infusion
• Adjust infusion rate in patients with renal or cardiac impairment
• Avoid rapid administration to prevent sudden shifts in serum sodium
• Use caution in patients with known hypersensitivity to any component
• Monitor for signs of fluid overload, especially in the elderly
• Ensure compatibility with other intravenous solutions before mixing

Glucosio Con Sodio Cloruro Iii Monico may interact with other medications, affecting electrolyte balance or glucose control. Review the patient’s medication list prior to use.

Avoid

• Concurrent high‑dose diuretics that may exacerbate sodium loss
• Intravenous hypertonic glucose solutions that could cause severe hyperglycemia
• Medications that prolong the QT interval when combined with rapid sodium shifts

Use with caution

• Insulin therapy, as glucose infusion may alter insulin requirements
• ACE inhibitors or ARBs, which can affect potassium and sodium homeostasis
• Corticosteroids, which may increase sodium retention and fluid volume